NCT00380263View on ClinicalTrials.gov

PACAP38´s (Pituitary Adenylate Cyclase-Activating Polypeptide) Headache Inducing Characteristics and Effects on the Cerebral Blood Flow

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Migraine Without Aura
Interventions
DRUG

PACAP38

10 pmol/kg/min given one time

Trial Locations (1)

2600

Dansih Headache Center, Glostrup Municipality

All Listed Sponsors
lead

Danish Headache Center

OTHER

NCT00380263 - PACAP38´s (Pituitary Adenylate Cyclase-Activating Polypeptide) Headache Inducing Characteristics and Effects on the Cerebral Blood Flow | Biotech Hunter | Biotech Hunter